These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 21915805)

  • 1. [Current treatment concepts of lung cancer].
    Kaiser F; Engelhardt M; Rawluk J; Mertelsmann R; Passlick B; Wäsch R
    Dtsch Med Wochenschr; 2011 Sep; 136(38):1901-6. PubMed ID: 21915805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Recommendations on the therapy of bronchial carcinoma].
    Thomas M; Baumann M; Deppermann M; Freitag L; Gatzemeier U; Huber R; Passlick B; Serke M; Ukena D
    Pneumologie; 2002 Feb; 56(2):113-31. PubMed ID: 11842350
    [No Abstract]   [Full Text] [Related]  

  • 3. [Bronchial cancer--development, diagnosis, therapy, prognosis].
    Zöchbauer S; Krajnik G; Huber H
    Wien Klin Wochenschr; 1994; 106(14):431-47. PubMed ID: 7941590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival of chemo-radiotherapy-treated and thermotherapy-treated patients with unresectable lung cancer.
    Rizzo S
    Oncol Rep; 1998; 5(3):667-71. PubMed ID: 9538173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The utility of p53 immunostaining of transbronchial biopsy specimens of lung cancer: p53 overexpression predicts poor prognosis and chemoresistance in advanced non-small cell lung cancer.
    Kawasaki M; Nakanishi Y; Kuwano K; Yatsunami J; Takayama K; Hara N
    Clin Cancer Res; 1997 Jul; 3(7):1195-200. PubMed ID: 9815799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lung cancer].
    Alexandersen O
    Tidsskr Nor Laegeforen; 2001 Feb; 121(4):407-9. PubMed ID: 11255851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lung cancer.
    Giaccone G; Smit EF
    Cancer Chemother Biol Response Modif; 2001; 19():485-534. PubMed ID: 11686030
    [No Abstract]   [Full Text] [Related]  

  • 8. Lung cancer treatment present and future.
    Cho JK
    Hawaii Med J; 2003 Mar; 62(3):61-2. PubMed ID: 12703177
    [No Abstract]   [Full Text] [Related]  

  • 9. Gaps in optimal care for lung cancer.
    Vinod SK; O'Connell DL; Simonella L; Delaney GP; Boyer M; Peters M; Miller D; Supramaniam R; McCawley L; Armstrong B
    J Thorac Oncol; 2008 Aug; 3(8):871-9. PubMed ID: 18670305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical trials referral resource. Clinical trials in lung cancer.
    Feigal EG; Cheson BD; Nelson AP
    Oncology (Williston Park); 1997 Nov; 11(11):1686, 1688, 1691, 1694. PubMed ID: 9394366
    [No Abstract]   [Full Text] [Related]  

  • 11. [To be cured of lung cancer].
    Depierre A; Jacoulet P; Westeel V; Falcoz PE
    Bull Cancer; 2002 Apr; 89(4):351-6. PubMed ID: 12016035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung cancer in New Zealand: patterns of secondary care and implications for survival.
    Stevens W; Stevens G; Kolbe J; Cox B
    J Thorac Oncol; 2007 Jun; 2(6):481-93. PubMed ID: 17545842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of survival and prognostic factors of 2,000 broncho-pulmonary cancers registered during 10 years in a multidisciplinary oncology department].
    Moro D; Nagy-Mignotte H; Bolla M; Colonna M; Brichon PY; Brambilla C; Schaerer R; Vrousos C
    Bull Cancer; 1997 Feb; 84(2):155-61. PubMed ID: 9180838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined modality treatment of lung cancer (NSCLC and SCLC).
    Delbaldo C; Le Péchoux C; Le Chevalier T
    Cancer Chemother Biol Response Modif; 2002; 20():677-95. PubMed ID: 12703230
    [No Abstract]   [Full Text] [Related]  

  • 15. Systemic and combined modality therapy for lung cancer.
    Ettinger DS
    Md Med J; 1990 Apr; 39(4):315-6. PubMed ID: 2159100
    [No Abstract]   [Full Text] [Related]  

  • 16. Auditing a new lung cancer service.
    Cullen JP; Glynn C; Murtagh E; Hogan B; Jeffers M; Lane SJ
    Ir Med J; 2004 Oct; 97(9):281-3. PubMed ID: 15568588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The trajectory of lung cancer patients in Western Australia--a data linkage study: still a grim tale.
    Jiwa M; Maujean E; Spilsbury K; Threlfal T
    Lung Cancer; 2010 Oct; 70(1):22-7. PubMed ID: 20129694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interventional palliative treatment options for lung cancer.
    Noppen N
    Ann Oncol; 2002; 13 Suppl 4():247-50. PubMed ID: 12401697
    [No Abstract]   [Full Text] [Related]  

  • 19. [Bronchial carcinoma. Epidemiology, diagnosis and therapy].
    Macha HN
    Internist (Berl); 2003 Jun; 44 Suppl 1():S28-34. PubMed ID: 14567086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reported management of lung cancer in Victoria in 1993: comparison with best practice. Anti-Cancer Council of Victoria Lung Cancer Study Group.
    Richardson GE; Thursfield VJ; Giles GG
    Med J Aust; 2000 Apr; 172(7):321-4. PubMed ID: 10844918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.